• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 蛋白锌(2+)结合口袋中的 G245C 和 G245D 取代导致 DNA 结合结构域构象灵活性的差异。

The substitutions G245C and G245D in the Zn(2+)-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain.

机构信息

Laboratory of Computational Proteomics, Institute of Cytology and Genetics SB RAS, Lavrentyev av. 10, Novosibirsk, 630090, Russia.

出版信息

J Biomol Struct Dyn. 2013;31(1):78-86. doi: 10.1080/07391102.2012.691364. Epub 2012 Jul 18.

DOI:10.1080/07391102.2012.691364
PMID:22803791
Abstract

Transcription activation of the proapoptotic target genes is a means by which the p53 protein implements its function of tumor suppression. Zn(2+) is a known regulator of p53 binding to the target genes. We have previously obtained an evidence that amino acid substitutions in the p53 Zn(2+)-binding pocket can presumably exert an influence on Zn(2+) position in the Zn(2+)-p53 complex and thereby affect p53 binding to DNA. With these background considerations, our aim was to estimate the effect of the putative changes in the Zn(2+) position in its binding pocket due to the G245C and G245D substitutions on the conformation of the p53 DNA-binding motif. Statistical analysis of the molecular dynamics (MD) trajectories of the mutant p53-Zn(2+) complexes was used to detect significant deviations in conformation of the mutant p53 forms. MD simulations demonstrated that (1) the two substitutions in the Zn(2+)-binding pocket caused changes in the conformation of the p53 DNA-binding motif, as compared with the wild-type (WT) p53; (2) binding of Zn(2+) to the p53 mutant forms reduced the effect of the substitutions on conformational change; and (3) Zn(2+) binding in the normal position compensated the effect of the mutations on the conformation in comparison to the altered Zn(2+) position.

摘要

转录激活促凋亡靶基因是 p53 蛋白发挥肿瘤抑制功能的一种方式。Zn(2+)是已知的调节 p53 与靶基因结合的物质。我们之前的研究结果表明,p53 的 Zn(2+)结合口袋中的氨基酸取代可能会影响 Zn(2+)在 Zn(2+)-p53 复合物中的位置,从而影响 p53 与 DNA 的结合。基于这些背景考虑,我们的目的是评估 G245C 和 G245D 取代导致的 Zn(2+)结合口袋中 Zn(2+)位置的可能变化对 p53 DNA 结合基序构象的影响。我们使用分子动力学(MD)轨迹的统计分析来检测突变 p53 形式构象的显著偏差。MD 模拟表明:(1)Zn(2+)结合口袋中的两个取代导致 p53 DNA 结合基序构象发生变化,与野生型(WT)p53 相比;(2)Zn(2+)与 p53 突变体的结合降低了取代对构象变化的影响;(3)与改变的 Zn(2+)位置相比,Zn(2+)在正常位置的结合补偿了突变对构象的影响。

相似文献

1
The substitutions G245C and G245D in the Zn(2+)-binding pocket of the p53 protein result in differences of conformational flexibility of the DNA-binding domain.p53 蛋白锌(2+)结合口袋中的 G245C 和 G245D 取代导致 DNA 结合结构域构象灵活性的差异。
J Biomol Struct Dyn. 2013;31(1):78-86. doi: 10.1080/07391102.2012.691364. Epub 2012 Jul 18.
2
Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.抑制性突变恢复突变型p53序列特异性DNA结合及反式激活作用的结构基础
J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30.
3
Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.在工程化的人类 p53 蛋白中,DNA 结合诱导的环 L1 构象开关的反转。
J Mol Biol. 2014 Feb 20;426(4):936-44. doi: 10.1016/j.jmb.2013.12.020. Epub 2013 Dec 27.
4
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.p53 DNA 结合结构域无锌形式的结构、功能及聚集情况
Biochemistry. 2003 Mar 4;42(8):2396-403. doi: 10.1021/bi026635n.
5
A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.一种细胞蛋白通过与中央保守区域相互作用来激活p53的序列特异性DNA结合。
Oncogene. 1996 Jan 4;12(1):193-200.
6
In vitro analysis of the dominant negative effect of p53 mutants.p53突变体显性负效应的体外分析
J Mol Biol. 1998 Aug 14;281(2):205-9. doi: 10.1006/jmbi.1998.1897.
7
R248Q mutation--Beyond p53-DNA binding.R248Q突变——超越p53与DNA的结合
Proteins. 2015 Dec;83(12):2240-50. doi: 10.1002/prot.24940. Epub 2015 Oct 27.
8
Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain.锌离子对p53 DNA结合结构域的DNA识别及稳定性的影响。
Biochemistry. 2006 Jun 20;45(24):7483-92. doi: 10.1021/bi0603165.
9
Specific DNA binding by different classes of human p53 mutants.不同类别人类p53突变体的特异性DNA结合
Oncogene. 1995 Aug 17;11(4):763-70.
10
Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
Oncogene. 1993 Dec;8(12):3421-6.

引用本文的文献

1
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.靶向突变型 p53:乳腺癌发病机制及其他方面的关键因素。
Cell Commun Signal. 2024 Oct 10;22(1):484. doi: 10.1186/s12964-024-01863-9.
2
Mutation-Mediated Immune Evasion in Cancer: Mechanisms and Therapeutic Implications.癌症中的突变介导免疫逃逸:机制与治疗意义
Cancers (Basel). 2024 Sep 3;16(17):3069. doi: 10.3390/cancers16173069.
3
p53 signaling in cancer progression and therapy.p53信号通路在癌症进展与治疗中的作用
Cancer Cell Int. 2021 Dec 24;21(1):703. doi: 10.1186/s12935-021-02396-8.
4
TP53 in Biology and Treatment of Osteosarcoma.TP53在骨肉瘤生物学与治疗中的作用
Cancers (Basel). 2021 Aug 25;13(17):4284. doi: 10.3390/cancers13174284.
5
Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer.胰腺癌中针对肿瘤抑制基因的治疗策略
Cancers (Basel). 2021 Aug 3;13(15):3920. doi: 10.3390/cancers13153920.
6
Structural and Drug Targeting Insights on Mutant p53.突变型p53的结构与药物靶向见解
Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344.
7
Current developments of targeting the p53 signaling pathway for cancer treatment.针对癌症治疗的 p53 信号通路的最新进展。
Pharmacol Ther. 2021 Apr;220:107720. doi: 10.1016/j.pharmthera.2020.107720. Epub 2020 Oct 29.
8
Regulating tumor suppressor genes: post-translational modifications.调控肿瘤抑制基因:翻译后修饰。
Signal Transduct Target Ther. 2020 Jun 10;5(1):90. doi: 10.1038/s41392-020-0196-9.
9
Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.突变型TP53 G245C和R273H促进食管鳞状细胞癌的细胞恶性增殖。
BMC Cell Biol. 2018 Aug 20;19(1):16. doi: 10.1186/s12860-018-0167-y.
10
Targeting Oncogenic Mutant p53 for Cancer Therapy.靶向致癌突变型p53用于癌症治疗。
Front Oncol. 2015 Dec 21;5:288. doi: 10.3389/fonc.2015.00288. eCollection 2015.